Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Reynaud, Rachel
SURMOUNT-ADOLESCENTS-2, NCT06439277: A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities	Recruiting	3	300	Europe, Canada, US, RoW	Tirzepatide, LY3298176, Placebo	Eli Lilly and Company	Obesity, Weight Gain	05/27	06/27
OTBB3-FU, NCT05032326: Long-term Interventional Follow-up Study of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical Trial	Recruiting	3	80	Europe	Follow-up study of the treated cohort, Follow-up study of the untreated cohort	University Hospital, Toulouse	Prader-Willi Syndrome	04/25	04/25
SEECLOOP, NCT06363916: Evaluation of Security and Efficacy of Medtrum Hybrid Closed Loop System	Recruiting	N/A	160	Europe	Insulin Management System in Manual mode of operation, Insulin Management System in Automatic mode of operation	Medtrum France, Axonal-Biostatem	Type 1 Diabetes	11/25	12/25
RADIANT, NCT05923827: Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults	Active, not recruiting	N/A	200	Europe	Omnipod 5 System	Insulet Corporation	Diabetes Mellitus, Type 1	08/24	08/25
COPEPCHILD, NCT06604975: Arginin-stimulated Copeptin in Polyuria-polydipsia Syndrome in Children	Not yet recruiting	N/A	155	Europe	Measure of Basal Copeptin level, Measure of arginine-stimulated copeptin, IRM, Water reduction at home	Assistance Publique Hopitaux De Marseille	Primary Polydipsia, Central Diabetes Insipidus, Nephrogenic Diabetes Insipidus	03/28	05/28